Glenn Mattes

Glenn Mattes brings more than 30 years of business leadership, global therapeutics development expertise, and executive management experience to his role with the company. As Chief Executive Officer, Mr. Mattes, has oversight of the direction and strategy at TFF Pharmaceuticals, facilitating company activity in business development, marketing, investor relations, commercialization alliances and channels, and management support. He works to share the company’s vision and strategy with partners, investors, and shareholders. Mr. Mattes is a former CEO of Tibotec Therapeutics and Rhone-Poulenc Rorer/Canada, in addition to other senior C-suite positions at Centocor and Johnson & Johnson. He was appointed to the President’s Advisory Council on HIV/AIDS by President George W. Bush and the U.S. Secretary of Health and Human Services. Mr. Mattes received a Bachelor of Science degree from the City University of New York.